Search details
1.
Opportunities for an early recognition of spinal muscular atrophy in primary care: a nationwide, population-based, study in Italy.
Fam Pract
; 40(2): 308-313, 2023 03 28.
Article
in English
| MEDLINE | ID: mdl-35950319
2.
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury.
Mol Biol Rep
; 47(4): 2941-2949, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32219772
3.
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol.
J Med Genet
; 56(5): 293-300, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30593463
4.
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care?
Neuropediatrics
; 46(1): 33-6, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25539139
5.
Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy.
PLoS One
; 17(7): e0271681, 2022.
Article
in English
| MEDLINE | ID: mdl-35905042
6.
Genetic modifiers of upper limb function in Duchenne muscular dystrophy.
J Neurol
; 269(9): 4884-4894, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35513612
7.
Type I SMA "new natural history": long-term data in nusinersen-treated patients.
Ann Clin Transl Neurol
; 8(3): 548-557, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33547876
8.
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy.
Neuromuscul Disord
; 31(6): 479-488, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33773883
9.
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up.
PLoS One
; 16(6): e0253882, 2021.
Article
in English
| MEDLINE | ID: mdl-34170974
10.
New aspects on patients affected by dysferlin deficient muscular dystrophy.
J Neurol Neurosurg Psychiatry
; 81(9): 946-53, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-19528035
11.
Respiratory function and therapeutic expectations in DMD: families experience and perspective.
Acta Myol
; 39(3): 121-129, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-33305168
12.
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors.
Cancer Treat Res Commun
; 24: 100203, 2020.
Article
in English
| MEDLINE | ID: mdl-32777750
13.
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study.
Front Genet
; 11: 131, 2020.
Article
in English
| MEDLINE | ID: mdl-32194622
14.
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.
PLoS One
; 14(6): e0218683, 2019.
Article
in English
| MEDLINE | ID: mdl-31237898
15.
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.
PLoS One
; 14(7): e0220714, 2019.
Article
in English
| MEDLINE | ID: mdl-31365579
16.
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements.
Neuromuscul Disord
; 27(5): 447-451, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28262469
17.
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs.
Acta Myol
; 36(2): 41-45, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28781515
18.
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions.
Acta Myol
; 36(1): 19-24, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28690390
19.
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study.
PLoS One
; 11(3): e0151445, 2016.
Article
in English
| MEDLINE | ID: mdl-26982196
20.
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.
PLoS One
; 9(10): e108205, 2014.
Article
in English
| MEDLINE | ID: mdl-25271887